Q2 2023 · 13F-HR
BAIN CAPITAL INVESTORS LLCholdings as filed
Filed 2023-08-14 · accession 0000950123-23-008164
$6.67B
Reported value
5
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 86881A100 | SGRY | SURGERY PARTNERS INC | $2.62B | 39.3% | 58,248,249 | Common | SOLE |
| G28923103 | — | DIVERSEY HLDGS LTD | $1.99B | 29.8% | 236,983,211 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $1.91B | 28.7% | 60,199,729 | Common | SOLE |
| 05356F105 | AVAH | AVEANNA HEALTHCARE HLDGS INC | $137.9M | 2.07% | 81,600,880 | Common | SOLE |
| 00791N102 | — | ADVANTAGE SOLUTIONS INC | $6.8M | 0.10% | 2,890,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.